The quality of life of the patients with diabetes type 2 using EQ-5D-5 L in Birjand

Abedini, Mohammad Reza; Bijari, Bita; Miri, Zahra; Shakhs Emampour, Fatemeh; Abbasi, Ali

doi:10.1186/s12955-020-1277-8

Health and Quality of Life Outcomes

Table 3 The abundance of problems (percentage) reported by the patients in terms of theire demographic and clinical characteristics

From: The quality of life of the patients with diabetes type 2 using EQ-5D-5 L in Birjand

variable		Mobility		Self Care		Usual Activities		Pain / Discomfort		Anxiety / Depression
variable		% of any problem	P value	% of any problem	P value	% of any problem	P value	% of any problem	P value	% of any problem	P value
sex	male	23	0.001	9.8	0.002	14.9	0.07	31.1	< 0.001	28.7	< 0.001
sex	female	42.1	0.001	24.2	0.002	23.6	0.07	56.5	< 0.001	53.9	< 0.001
Age group	≤50y	16.1	0.005	12.5	0.31	3.6	0.001	32.1	0.10	37.5	0.53
	51-60y	40.3		21.8		28.8		47.9		43.7
	>60y	36.8		17.6		19.2		48		46.4
Job	Employed	18.2	0.002	6.5	0.007	11.8	0.10	26	< 0.001	24.7	< 0.001
	housewife	42.1		21.4		22.1		57.2		52.4
	others	35.9		24.4		24.4		41		46.2
Education	Illiterate	43.1	0.29	20.7	0.17	20.7	0.54	53.4	0.29	48.3	0.42
	undergraduate	32		14.4		17.8		44.4		45.1
	postgraduate	32.6		23.6		23.6		40.4		38.2
Residency	Urban	33.3	0.18	16.8	0.01	18.7	0.03	44.1	0.24	41.9	0.02
Residency	rural	47.6	0.18	38.1	0.01	38.1	0.03	57.1	0.24	66.7	0.02
treatment	Oral drug	31.3	0.06	14.5	0.005	17.6	0.05	42.7	0.13	43.2	0.69
treatment	insulin	43.1	0.06	29.2	0.005	28.2	0.05	52.8	0.13	45.8	0.69
HbA1C	< 7	24.6	0.08	10.5	0.09	16.1	0.40	42.1	0.62	43.9	0.97
HbA1C	≥7	36.6	0.08	20.2	0.09	21	0.40	45.7	0.62	43.6	0.97
duration	<10y	28.6	0.006	14.3	0.01	15.3	0.008	43.9	0.62	41.3	0.27
duration	≥10y	44.1	0.006	25.2	0.01	28.2	0.008	46.8	0.62	47.7	0.27
Nephropathy	yes	46.4	0.03	25	0.15	23.6	0.46	64.3	0.001	53.6	0.09
Nephropathy	no	31.6	0.03	16.8	0.15	19.3	0.46	40.6	0.001	41.4	0.09
Retinopathy	yes	41	0.13	20.5	0.55	24.1	0.33	50.6	0.22	43.4	0.95
Retinopathy	no	31.8	0.13	17.5	0.55	18.5	0.33	42.9	0.22	43.8	0.95
Neuropathy	yes	62.5	< 0.001	25	0.30	37.5	0.009	68.8	0.004	53.1	0.25
Neuropathy	no	31	< 0.001	17.5	0.30	18	0.009	42.2	0.004	42.5	0.25
IHD	yes	40	0.41	22.9	0.48	22.9	0.71	47.1	0.61	45.7	0.63
IHD	no	32.8	0.41	17	0.48	19.3	0.71	44.5	0.61	43.2	0.63
Diabetes related hospitalization	yes	42.1	0.008	20.7	0.31	25	0.04	50	0.10	48.6	0.10
Diabetes related hospitalization	no	27.5	0.008	16.3	0.31	15.7	0.04	40.6	0.10	39.4	0.10

Back to article page

ISSN: 1477-7525

Contact us

Submission enquiries: journalsubmissions@springernature.com